{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:58:32Z","timestamp":1793674712018,"version":"4.5.1"},"reference-count":209,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Hepatobiliary cancers are major contributors to cancer-related mortality, mainly due to late-stage diagnosis, poor prognosis, and limited effectiveness of current treatments in advanced disease. Standard therapies comprise surgical resection, liver transplantation, and systemic agents including tyrosine kinase inhibitors and immune checkpoint inhibitors, but their efficacy is often hindered by the development of drug resistance, underlying the urgent need for novel therapeutic strategies. Lipid nanoparticles (LNPs) have emerged as promising delivery vehicles due to their favorable physicochemical properties, enabling the transport of natural biomolecules or engineered drugs for targeted tumor therapy. LNPs are also being explored as platforms for cancer therapy and vaccines. Moreover, recent advances underscore the key role of extracellular vesicles (EVs) in modulating the tumor microenvironment, promoting tumor progression, chemoresistance, and escape from immune recognition and destruction (immune evasion) in hepatobiliary cancers. EVs are being investigated both as biomarkers for early detection and as therapeutic agents, with engineered or drug-loaded EVs showing potential for targeted drug delivery and tissue repair in liver diseases, including cancer. This review highlights the potential of cell-free therapeutic LNP- and EV-based platforms, standalone or in combination, for RNA, small molecules and proteins delivery in improving diagnosis and treatment outcomes in hepatobiliary cancers, in particular, hepatocellular carcinoma and cholangiocarcinoma.<\/jats:p>","DOI":"10.3389\/fcell.2026.1812373","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:21:47Z","timestamp":1779949307000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Lipid nanoparticles and extracellular vesicles: emerging cell free therapeutic platforms for hepatobiliary cancers"],"prefix":"10.3389","volume":"14","author":[{"given":"Gabriele","family":"Saccu","sequence":"first","affiliation":[{"name":"Boston Children\u2019s Hospital, Pathology Department, Harvard University","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Fagoonee","sequence":"additional","affiliation":[{"name":"Institute of Biostructure and Bioimaging (CNR) and Molecular Biotechnology Center \u201cGuido Tarone\u201d","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","article-title":"Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake","volume":"36","author":"Abels","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"115104","DOI":"10.1016\/j.biopha.2023.115104","article-title":"Recent progress in the immunotherapy of hepatocellular carcinoma: non-coding RNA-based immunotherapy may improve the outcome","volume":"165","author":"Afra","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/ph18050746","article-title":"Harnessing the power of nanocarriers to exploit the tumor microenvironment for enhanced cancer therapy","volume":"18","author":"Aldhubiab","year":"2025","journal-title":"Pharm. (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/cimb47121056","article-title":"Cancer vaccines: molecular mechanisms, clinical progress, and combination immunotherapies with a focus on hepatocellular carcinoma","volume":"47","author":"Alrumaihi","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1208\/s12248-025-01051-8","article-title":"Lipid nanoparticles for mRNA delivery in cancer immunotherapy","volume":"27","author":"Alshehry","year":"2025","journal-title":"AAPS J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.3390\/jcm12237469","article-title":"The complexity of the tumor microenvironment in hepatocellular carcinoma and emerging therapeutic developments","volume":"12","author":"Argentiero","year":"2023","journal-title":"J. Clin. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e12241","DOI":"10.1002\/jev2.12241","article-title":"Non-Invasive imaging of extracellular vesicles: Quo vaditis in vivo?","volume":"11","author":"Arifin","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/cancers16071415","article-title":"Extracellular vesicle-related non-coding RNAs in hepatocellular carcinoma: an overview","volume":"16","author":"Augello","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3390\/cells8121560","article-title":"Extracellular vesicles-encapsulated MicroRNA-125b produced in genetically modified mesenchymal stromal cells inhibits hepatocellular carcinoma cell proliferation","volume":"8","author":"Baldari","year":"2019","journal-title":"Cells"},{"key":"B12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1021\/acs.molpharmaceut.4c00514","article-title":"The chemo-immunotherapeutic roles of tumor-derived extracellular vesicle-based paclitaxel delivery system in hepatocarcinoma","volume":"21","author":"Bi","year":"2024","journal-title":"Mol. Pharm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"10817","DOI":"10.1021\/acsnano.8b02587","article-title":"Tumor cell-derived extracellular vesicle-coated nanocarriers: an efficient theranostic platform for the cancer-specific delivery of anti-miR-21 and imaging agents","volume":"12","author":"Bose","year":"2018","journal-title":"ACS Nano"},{"key":"B16","doi-asserted-by":"publisher","first-page":"10401","DOI":"10.3390\/ijms251910401","article-title":"Basic guide for approaching drug delivery with extracellular vesicles","volume":"25","author":"Brezgin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/ijc.32925","article-title":"Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo","volume":"147","author":"Brossa","year":"2020","journal-title":"Int. J. Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"102955","DOI":"10.1016\/j.ctrv.2025.102955","article-title":"The present and the future of immunotherapy in hepatocellular carcinoma and biliary tract cancers","volume":"137","author":"Cabibbo","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/vaccines9010061","article-title":"Immune responses induced by mRNA vaccination in mice, monkeys and humans","volume":"9","author":"Cagigi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1016\/j.cell.2025.11.023","article-title":"Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses","volume":"188","author":"Casta\u00f1o","year":"2025","journal-title":"Cell."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.ymthe.2023.01.021","article-title":"Extracellular vesicles: the next generation in gene therapy delivery","volume":"31","author":"Cecchin","year":"2023","journal-title":"Mol. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.3390\/cancers14112798","article-title":"Emerging therapies for hepatocellular carcinoma (HCC)","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1002\/mco2.315","article-title":"Applications of multi-omics analysis in human diseases","volume":"4","author":"Chen","year":"","journal-title":"MedComm (2020)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41416-024-02684-w","article-title":"The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications","volume":"131","author":"Chen","year":"2024","journal-title":"Br. J. Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"106688","DOI":"10.1016\/j.ejps.2023.106688","article-title":"Recent advances and clinical translation of liposomal delivery systems in cancer therapy","volume":"193","author":"Chen","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"107419","DOI":"10.1016\/j.phrs.2024.107419","article-title":"Extracellular vesicles in the HCC microenvironment: implications for therapy and biomarkers","volume":"209","author":"Cheng","year":"2024","journal-title":"Pharmacol. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1038\/s41467-025-58523-w","article-title":"Liposomal lipid nanoparticles for extrahepatic delivery of mRNA","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e22172","DOI":"10.1002\/adma.202522172","article-title":"Rethinking extracellular vesicle signaling","volume":"38","author":"Chrzanowski","year":"2026","journal-title":"Adv. Mater"},{"key":"B30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12929-018-0494-5","article-title":"Imaging extracellular vesicles: current and emerging methods","volume":"25","author":"Chuo","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis Pr","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"B32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/10_2019_118","article-title":"Addressing the manufacturing challenges of cell-based therapies","volume":"171","author":"de Almeida Fuzeta","year":"2020","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/cancers16071370","article-title":"Identification of two distinct immune subtypes in hepatitis B virus (HBV)-Associated hepatocellular carcinoma (HCC)","volume":"16","author":"De Battista","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"975408","DOI":"10.3389\/fonc.2022.975408","article-title":"An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma","volume":"12","author":"Deng","year":"2022","journal-title":"Front. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41580-023-00576-0","article-title":"Context-specific regulation of extracellular vesicle biogenesis and cargo selection","volume":"24","author":"Dixson","year":"2023","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.1038\/s41467-023-42365-5","article-title":"Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer","volume":"14","author":"Dong","year":"2023","journal-title":"Nat. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3390\/cells13231935","article-title":"MicroRNAs and RNA-binding protein-based regulation of bone metastasis from hepatobiliary cancers and potential therapeutic strategies","volume":"13","author":"Fagoonee","year":"2024","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"102166","DOI":"10.1016\/j.cis.2020.102166","article-title":"Morphology and microstructural analysis of bioactive-loaded micro\/nanocarriers via microscopy techniques; CLSM\/SEM\/TEM\/AFM","volume":"280","author":"Falsafi","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jconrel.2019.07.036","article-title":"Functionalized theranostic nanocarriers with bio-inspired polydopamine for tumor imaging and chemo-photothermal therapy","volume":"309","author":"Farokhi","year":"2019","journal-title":"J. Control Release"},{"key":"B42","article-title":"Extracellular vesicles as delivery vehicles for non-coding RNAs: potential biomarkers for chronic liver diseases","volume-title":"Biomolecules","author":"Ferro","year":"2024"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1007\/s00432-022-04325-2","article-title":"Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development","volume":"149","author":"Fu","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12967-024-06033-6","article-title":"mRNA vaccines in the context of cancer treatment: from concept to application","volume":"23","author":"Fu","year":"2025","journal-title":"J. Transl. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.3390\/ijms24076615","article-title":"Liposomes in cancer therapy: how did we start and where are we now","volume":"24","author":"Fulton","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e2009","DOI":"10.1002\/wnan.2009","article-title":"Unveiling invisible extracellular vesicles: cutting-edge technologies for their in vivo visualization","volume":"16","author":"Gangadaran","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed Nanobiotechnol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1688","DOI":"10.1002\/wnan.1688","article-title":"Imaging as a tool to accelerate the translation of extracellular vesicle-based therapies for central nervous system diseases","volume":"13","author":"Gao","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed Nanobiotechnol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1021\/acs.nanolett.3c04463","article-title":"Quantitative label-free chemical imaging of PLGA nanoparticles in cells and tissues with single-particle sensitivity","volume":"24","author":"Gao","year":"2024","journal-title":"Nano Lett."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/s41467-025-57367-8","article-title":"HBV-associated hepatocellular carcinomas inhibit antitumor CD8","volume":"16","author":"Gao","year":"2025","journal-title":"Nat. Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/cells11091375","article-title":"Insight into extracellular vesicle-cell communication: from cell recognition to intracellular fate","volume":"11","author":"Ginini","year":"2022","journal-title":"Cells"},{"key":"B51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamasurg.2023.6083","article-title":"Liver transplant as a treatment of primary and secondary liver neoplasms","volume":"159","author":"Gorji","year":"2024","journal-title":"JAMA Surg."},{"key":"B52","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/path.6138","article-title":"Extracellular vesicles arising from apoptosis: forms, functions, and applications","volume":"260","author":"Gregory","year":"2023","journal-title":"J. Pathol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-025-09655-y","article-title":"SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade","volume":"647","author":"Grippin","year":"2025","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/gt.2017.5","article-title":"Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems","volume":"24","author":"Guan","year":"2017","journal-title":"Gene Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/hep.31325","article-title":"Surgical treatments of hepatobiliary cancers","volume":"73","author":"Gunasekaran","year":"2021","journal-title":"Hepatology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1800222","DOI":"10.1080\/20013078.2020.1800222","article-title":"Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging","volume":"9","author":"Gupta","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"B57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/14737140.2023.2183844","article-title":"Emerging treatment strategies in hepatobiliary cancer","volume":"23","author":"Guven","year":"2023","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3390\/cancers15072070","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"15","author":"Hagiwara","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"21877","DOI":"10.1021\/acsami.3c01501","article-title":"Lipid nanoparticle delivery of small proteins for potent","volume":"15","author":"Haley","year":"2023","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.omto.2020.08.017","article-title":"Valeric acid suppresses liver cancer development by acting as a novel HDAC inhibitor","volume":"19","author":"Han","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/pharmaceutics16010059","article-title":"Sensitizing the efficiency of ICIs by neoantigen mRNA vaccines for HCC treatment","volume":"16","author":"Han","year":"2023","journal-title":"Pharmaceutics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1158\/1538-7445.AM2025-2792","article-title":"PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening [ Abstract nr 2792 ]. Proceedings of the American Association for Cancer Research Annual Meeting 2025","volume":"85","author":"Han","year":"2025","journal-title":"Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12951-023-01902-6","article-title":"Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1\/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells","volume":"21","author":"He","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3390\/cancers15072088","article-title":"Extracellular vesicles act as carriers for cargo delivery and regulate Wnt signaling in the hepatocellular carcinoma tumor microenvironment","volume":"15","author":"He","year":"","journal-title":"Cancers (Basel)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41419-025-07401-w","article-title":"The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21","volume":"16","author":"He","year":"2025","journal-title":"Cell. Death Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1186\/s12967-025-07077-y","article-title":"Extracellular vesicles for targeted drug delivery: advances in surface modification strategies and therapeutic applications","volume":"23","author":"Hu","year":"2025","journal-title":"J. Transl. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-021-01342-6","article-title":"Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development","volume":"20","author":"Huang","year":"2021","journal-title":"Mol. Cancer"},{"key":"B69","doi-asserted-by":"publisher","first-page":"13007","DOI":"10.2147\/IJN.S548006","article-title":"Extracellular vesicle-based therapeutic cargo delivery for cancer therapy","volume":"20","author":"Huang","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"B70","doi-asserted-by":"publisher","first-page":"11111","DOI":"10.1038\/s41467-025-66087-y","article-title":"Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s13287-025-04708-5","article-title":"Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatments","volume":"16","author":"Hwang","year":"2025","journal-title":"Stem Cell. Res. Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/hep4.1462","article-title":"Targeting liver cancer stem cells using engineered biological nanoparticles for the treatment of hepatocellular cancer","volume":"4","author":"Ishiguro","year":"2020","journal-title":"Hepatol. Commun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.tranon.2023.101634","article-title":"Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: a systematic review","volume":"31","author":"Ito","year":"2023","journal-title":"Transl. Oncol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e2407850","DOI":"10.1002\/advs.202407850","article-title":"Barcoded hybrids of extracellular vesicles and lipid nanoparticles for multiplexed analysis of tissue distribution","volume":"12","author":"Ivanova","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/cancers16071271","article-title":"Locoregional therapies for hepatobiliary tumors: contemporary strategies and novel applications","volume":"16","author":"Jipa","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1021\/acs.molpharmaceut.2c00442","article-title":"Lipid nanoparticle (LNP) chemistry can endow unique","volume":"19","author":"Johnson","year":"2022","journal-title":"Mol. Pharm."},{"key":"B77","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1038\/s41598-024-55888-8","article-title":"Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma","volume":"14","author":"Juratli","year":"2024","journal-title":"Sci. Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3390\/cancers15082219","article-title":"Minimally invasive anatomic liver resection for hepatocellular carcinoma using the extrahepatic glissonian approach: surgical techniques and comparison of outcomes with the open approach and between the laparoscopic and robotic approaches","volume":"15","author":"Kato","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int."},{"key":"B81","doi-asserted-by":"publisher","first-page":"LBA9503","DOI":"10.1200\/jco.2023.41.17_suppl.lba9503","article-title":"Distant metastasis-free survival results from the randomized, phase 2 mRNA-4157-P201\/KEYNOTE-942 trial","volume":"41","author":"Khattak","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41571-024-00867-1","article-title":"Personalized neoantigen mRNA vaccine mitigates melanoma recurrence","volume":"21","author":"Killock","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3350\/cmh.2024.0318","article-title":"Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023","volume":"30","author":"Kim","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.7150\/thno.93115","article-title":"Extracellular vesicles as carriers of mRNA: opportunities and challenges in diagnosis and treatment","volume":"14","author":"Kirian","year":"2024","journal-title":"Theranostics"},{"key":"B85","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1158\/1078-0432.CCR-14-0314","article-title":"Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I\/II-restricted epitopes for pancreatic cancer","volume":"20","author":"Koido","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-025-02233-w","article-title":"Extracellular vesicles in tumor immunity: mechanisms and novel insights","volume":"24","author":"Kuang","year":"2025","journal-title":"Mol. Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40425-018-0431-x","article-title":"Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma","volume":"6","author":"Lai","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.3390\/cancers13153657","article-title":"Current surgical management of Peri-Hilar and intra-hepatic cholangiocarcinoma","volume":"13","author":"Lauterio","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2313696","DOI":"10.1080\/15476278.2024.2313696","article-title":"Lipid nanovesicle platforms for hepatocellular carcinoma precision medicine therapeutics: progress and perspectives","volume":"20","author":"Lehrich","year":"2024","journal-title":"Organogenesis"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1158\/1535-7163.MCT-12-0983-T","article-title":"Developing lipid nanoparticle-based siRNA therapeutics for hepatocellular carcinoma using an integrated approach","volume":"12","author":"Li","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.28735","article-title":"Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model","volume":"65","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jconrel.2020.08.056","article-title":"Emerging strategies for labeling and tracking of extracellular vesicles","volume":"328","author":"Li","year":"2020","journal-title":"J. Control Release"},{"key":"B95","doi-asserted-by":"publisher","first-page":"20240109","DOI":"10.1002\/EXP.20240109","article-title":"Extracellular vesicle-based mRNA therapeutics and vaccines","volume":"5","author":"Li","year":"2025","journal-title":"Explor. (Beijing)"},{"key":"B96","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"B97","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13578-024-01294-6","article-title":"Role of extracellular vesicle-associated proteins in the progression, diagnosis, and treatment of hepatocellular carcinoma","volume":"14","author":"Liu","year":"2024","journal-title":"Cell. Biosci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e2417357","DOI":"10.1002\/advs.202417357","article-title":"Effect of extracellular vesicles derived from tumor cells on immune evasion","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B99","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinomas","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B100","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2016.06.027","article-title":"Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient","volume":"65","author":"L\u00f6ffler","year":"2016","journal-title":"J. Hepatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials on mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-019-1512-5","article-title":"MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway","volume":"39","author":"Lou","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1016\/j.matt.2024.09.012","article-title":"Engineered extracellular vesicles as a next-generation vaccine platform","volume":"7","author":"Lu","year":"2024","journal-title":"Matter"},{"key":"B104","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12951-022-01309-9","article-title":"Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances","volume":"20","author":"Mahmoud","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/hep4.1311","article-title":"Extracellular vesicle-based therapeutic targeting of \u03b2-catenin to modulate anticancer immune responses in hepatocellular cancer","volume":"3","author":"Matsuda","year":"2019","journal-title":"Hepatol. Commun."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3390\/cancers17091408","article-title":"Advancing cancer treatment: a review of immune checkpoint inhibitors and combination strategies","volume":"17","author":"Mc Neil","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jconrel.2024.12.010","article-title":"Extracellular vesicles-based vaccines: emerging immunotherapies against cancer","volume":"378","author":"Meng","year":"2025","journal-title":"J. Control Release"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1080\/1061186X.2025.2479757","article-title":"Redefining hepatocellular carcinoma treatment: nanotechnology meets tumor immune microenvironment","volume":"33","author":"Mi","year":"2025","journal-title":"J. Drug Target"},{"key":"B109","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.7150\/jca.98426","article-title":"Unlocking the secrets of extracellular vesicles: orchestrating tumor microenvironment dynamics in metastasis, drug resistance, and immune evasion","volume":"15","author":"Mir","year":"2024","journal-title":"J. Cancer"},{"key":"B111","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.25.634881","article-title":"Targeted delivery of mRNA to the heart via extracellular vesicles or lipid nanoparticles","author":"Nawaz","year":"2025","journal-title":"bioRxiv"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41467-022-29122-w","article-title":"Trajectory of immune evasion and cancer progression in hepatocellular carcinoma","volume":"13","author":"Nguyen","year":"2022","journal-title":"Nat. Commun."},{"key":"B114","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.1002\/cam4.4370","article-title":"Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma","volume":"10","author":"Nimitrungtawee","year":"2021","journal-title":"Cancer Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","article-title":"RNA delivery by extracellular vesicles in mammalian cells and its applications","volume":"21","author":"O'Brien","year":"2020","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/cancers12051237","article-title":"Biliary tract cancer: current medical treatment strategies","volume":"12","author":"Oneda","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.3390\/ijms24087287","article-title":"Extracellular vesicles for therapeutic nucleic acid delivery: loading strategies and challenges","volume":"24","author":"Oshchepkova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"15330338221097203","DOI":"10.1177\/15330338221097203","article-title":"Hepatobiliary cancers: progress in diagnosis, pathogenesis, and treatment","volume":"21","author":"Pant","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"key":"B119","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3390\/cancers12040823","article-title":"The crosstalk between tumor cells and the microenvironment in hepatocellular carcinoma: the role of exosomal microRNAs and their clinical implications","volume":"12","author":"Pascut","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B120","doi-asserted-by":"publisher","first-page":"101302","DOI":"10.1016\/j.mam.2024.101302","article-title":"Extracellular vesicles transport RNA between cells: unraveling their dual role in diagnostics and therapeutics","volume":"99","author":"Payandeh","year":"2024","journal-title":"Mol. Asp. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.3390\/ijms26135994","article-title":"Systemic therapy for unresectable hepatocellular carcinoma: current landscape and future directions","volume":"26","author":"Philippi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e26278","DOI":"10.1002\/adfm.202526278","article-title":"Controlling payload heterogeneity in lipid nanoparticles for RNA-based therapeutics","volume":"36","author":"Pial","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"B123","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtm.2019.01.001","article-title":"Improved loading of plasma-derived extracellular vesicles to encapsulate antitumor miRNAs","volume":"13","author":"Pomatto","year":"2019","journal-title":"Mol. Therapy. Methods & Clinical Development"},{"key":"B124","doi-asserted-by":"publisher","first-page":"620498","DOI":"10.3389\/fcell.2021.620498","article-title":"Biological functions driven by mRNAs carried by extracellular vesicles in cancer","volume":"9","author":"Prieto-Vila M","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41541-023-00733-8","article-title":"mRNA-LNP vaccination-based immunotherapy augments CD8","volume":"8","author":"Qiu","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ymthe.2023.02.013","article-title":"Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading","volume":"31","author":"R\u00e4dler","year":"2023","journal-title":"Mol. Ther."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3390\/ijms21072286","article-title":"Extracellular vesicles and tumor-immune escape: biological functions and clinical perspectives","volume":"21","author":"Raimondo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1021\/jacsau.3c00611","article-title":"Extracellular vesicles for drug delivery and theranostics","volume":"4","author":"Rakshit","year":"2024","journal-title":"JACS Au"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/jpm14111092","article-title":"Advances in mRNA LNP-based cancer vaccines: mechanisms, formulation aspects, challenges, and future directions","volume":"14","author":"Ramadan","year":"2024","journal-title":"J. Pers. Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13046-025-03291-0","article-title":"TGF-\u03b2 induces cholesterol accumulation to regulate the secretion of tumor-derived extracellular vesicles","volume":"44","author":"Rodrigues-Junior","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"B133","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcdb.2021.04.006","article-title":"Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma","volume":"124","author":"Roy","year":"2022","journal-title":"Semin. Cell. Dev. Biol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"102192","DOI":"10.1016\/j.tranon.2024.102192","article-title":"Comparative transcriptomic analysis uncovers molecular heterogeneity in hepatobiliary cancers","volume":"51","author":"Roy","year":"2025","journal-title":"Transl. Oncol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"101975","DOI":"10.1016\/j.tranon.2024.101975","article-title":"Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy","volume":"45","author":"Samaei","year":"2024","journal-title":"Transl. Oncol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1158\/1078-0432.CCR-20-0414","article-title":"MTL-CEBPA, a small activating RNA therapeutic upregulating C\/EBP-\u03b1, in patients with advanced liver cancer: a first-in-human, multicenter, open-label, phase I trial","volume":"26","author":"Sarker","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"114470","DOI":"10.1016\/j.ejpb.2024.114470","article-title":"MiR-29a-laden extracellular vesicles efficiently induced apoptosis through autophagy blockage in HCC cells","volume":"203","author":"Seydi","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B139","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41392-024-02002-z","article-title":"Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"B140","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00534-011-0437-y","article-title":"Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma","volume":"19","author":"Shimizu","year":"2012","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.3390\/cancers12103019","article-title":"EVs as potential new therapeutic tool\/target in gastrointestinal cancer and HCC","volume":"12","author":"S\u0142omka","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B142","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/jnci\/djad046","article-title":"Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma","volume":"115","author":"Spencer","year":"2023","journal-title":"J. Natl. Cancer Inst."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1485628","DOI":"10.3389\/fimmu.2024.1485628","article-title":"Extracellular vesicles in hepatocellular carcinoma: unraveling immunological mechanisms for enhanced diagnosis and overcoming drug resistance","volume":"15","author":"Su","year":"2024","journal-title":"Front. Immunol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1038\/s41467-020-18311-0","article-title":"Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring","volume":"11","author":"Sun","year":"2020","journal-title":"Nat. Commun."},{"key":"B145","doi-asserted-by":"publisher","first-page":"9534","DOI":"10.1021\/acs.langmuir.0c01512","article-title":"Nafion-based nanocarriers for fluorine magnetic resonance imaging","volume":"36","author":"Szcz\u0119ch","year":"2020","journal-title":"Langmuir"},{"key":"B146","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40779-022-00399-8","article-title":"mRNA vaccine development for cholangiocarcinoma: a precise pipeline","volume":"9","author":"Tang","year":"2022","journal-title":"Mil. Med. Res."},{"key":"B147","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12964-020-00643-5","article-title":"Role of extracellular vesicles in tumour microenvironment","volume":"18","author":"Tao","year":"2020","journal-title":"Cell. Commun. Signal"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1400744","DOI":"10.3389\/fimmu.2024.1400744","article-title":"Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis","volume":"15","author":"Tian","year":"2024","journal-title":"Front. Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/vaccines11081357","article-title":"A comprehensive review on cancer vaccines and vaccine strategies in hepatocellular carcinoma","volume":"11","author":"Tojjari","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B151","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1001\/jamasurg.2025.0242","article-title":"Molecular testing and targeted therapies in hepatobiliary cancers: a review","volume":"160","author":"Tsilimigras","year":"2025","journal-title":"JAMA Surg."},{"key":"B152","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.3390\/cancers14153674","article-title":"Precision medicine of hepatobiliary and pancreatic cancers: focusing on clinical trial outcomes","volume":"14","author":"Tsumura","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B153","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/nano9030341","article-title":"Raman imaging of nanocarriers for drug delivery","volume":"9","author":"Vanden-Hehir","year":"2019","journal-title":"Nanomater. (Basel)"},{"key":"B154","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J. Control Release"},{"key":"B155","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1096\/fba.2021-00081","article-title":"In vivo imaging of EVs in zebrafish: new perspectives from the waterside","volume":"3","author":"Verdi","year":"2021","journal-title":"FASEB Bioadv"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41592-021-01206-3","article-title":"The power of imaging to understand extracellular vesicle biology in vivo","volume":"18","author":"Verweij","year":"2021","journal-title":"Nat. Methods"},{"key":"B157","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cancers16040766","article-title":"Noncoding RNAs in hepatocellular carcinoma: potential applications in combined therapeutic strategies and promising candidates of treatment response","volume":"16","author":"Vianello","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1029069","DOI":"10.3389\/fimmu.2022.1029069","article-title":"mRNA vaccines for cancer immunotherapy","volume":"13","author":"Vishweshwaraiah","year":"2022","journal-title":"Front. Immunol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jamasurg.2024.1184","article-title":"Liver resection vs nonsurgical treatments for patients with early multinodular hepatocellular carcinoma","volume":"159","author":"Vitale","year":"2024","journal-title":"JAMA Surg."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"B161","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.7150\/thno.37097","article-title":"Extracellular vesicle-based drug delivery systems for cancer treatment","volume":"9","author":"Walker","year":"2019","journal-title":"Theranostics"},{"key":"B162","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/hep.29586","article-title":"Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma","volume":"67","author":"Wang","year":"2018","journal-title":"Hepatology"},{"key":"B163","doi-asserted-by":"publisher","first-page":"e2007603","DOI":"10.1002\/adma.202007603","article-title":"mRNA delivery of a bispecific single-domain antibody to polarize tumor-associated macrophages and synergize immunotherapy against liver malignancies","volume":"33","author":"Wang","year":"2021","journal-title":"Adv. Mater"},{"key":"B164","doi-asserted-by":"publisher","first-page":"e2101557","DOI":"10.1002\/adhm.202101557","article-title":"RNA and protein delivery by cell-secreted and bioengineered extracellular vesicles","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthc. Mater"},{"key":"B165","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06114-4","article-title":"Tumour extracellular vesicles and particles induce liver metabolic dysfunction","volume":"618","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","article-title":"Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment","volume":"35","author":"Wang","year":"2023","journal-title":"Cell. Metab."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1215518","DOI":"10.3389\/fbioe.2023.1215518","article-title":"Spotlights on extracellular vesicles in hepatocellular carcinoma diagnosis and treatment: an update review","volume":"11","author":"Wang","year":"","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1002\/mco2.667","article-title":"Circular RNA-based neoantigen vaccine for hepatocellular carcinoma immunotherapy","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1334592","DOI":"10.3389\/fonc.2024.1334592","article-title":"Clinical significance of small extracellular vesicles in cholangiocarcinoma","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Oncol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"148874","DOI":"10.1016\/j.gene.2024.148874","article-title":"Exosomal delivery of miR-200b-3p suppresses the growth of hepatocellular carcinoma cells by targeting ERG- and VEGF-mediated angiogenesis","volume":"931","author":"Wang","year":"","journal-title":"Gene"},{"key":"B171","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/vaccines13050502","article-title":"Unlocking mRNA vaccine potential in liver cancer treatment via synergistic bile acid modulation","volume":"13","author":"Wang","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B172","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"B173","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13045-021-01141-y","article-title":"Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer","volume":"14","author":"Weng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11864-023-01153-5","article-title":"Current standards, multidisciplinary approaches, and future directions in the management of extrahepatic cholangiocarcinoma","volume":"25","author":"Wheless","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"26316","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"B176","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nbt.3298","article-title":"Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown","volume":"33","author":"Wittrup","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12943-024-02136-2","article-title":"Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery","volume":"23","author":"Wu","year":"2024","journal-title":"Mol. Cancer"},{"key":"B178","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.3390\/ijms26104835","article-title":"Extracellular vesicle-based drug delivery systems in cancer therapy","volume":"26","author":"Wu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2024.25","article-title":"RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives","volume":"10","author":"Xing","year":"2024","journal-title":"Hepatoma Res."},{"key":"B180","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.biomaterials.2008.09.014","article-title":"The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma","volume":"30","author":"Xu","year":"2009","journal-title":"Biomaterials"},{"key":"B181","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","article-title":"Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"B182","doi-asserted-by":"publisher","first-page":"eaat9039","DOI":"10.1126\/sciadv.aat9039","article-title":"Mass spectrometry imaging of the in situ drug release from nanocarriers","volume":"4","author":"Xue","year":"2018","journal-title":"Sci. Adv."},{"key":"B183","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.hbpd.2022.08.014","article-title":"Novel cellular therapies for hepatobiliary malignancies","volume":"21","author":"Xue","year":"2022","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"B184","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.3390\/cells11172642","article-title":"Desialylated mesenchymal stem cells-derived extracellular vesicles loaded with doxorubicin for targeted inhibition of hepatocellular carcinoma","volume":"11","author":"Yang","year":"2022","journal-title":"Cells"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1097\/HEP.0000000000000005","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatology"},{"key":"B186","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"2307187","DOI":"10.1080\/21645515.2024.2307187","article-title":"Recent progress in mRNA cancer vaccines","volume":"20","author":"Yao","year":"2024","journal-title":"Hum. Vaccin Immunother."},{"key":"B188","doi-asserted-by":"publisher","first-page":"100562","DOI":"10.1016\/j.medj.2024.11.015","article-title":"Clinical advances of mRNA vaccines for cancer immunotherapy","volume":"6","author":"Yaremenko","year":"2025","journal-title":"Med"},{"key":"B189","doi-asserted-by":"publisher","first-page":"117228","DOI":"10.1016\/j.bios.2025.117228","article-title":"Tidal microfluidic chip-based isolation and transcriptomic profiling of plasma extracellular vesicles for clinical monitoring of high-risk patients with hepatocellular carcinoma-associated precursors","volume":"276","author":"Yi","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1330400","DOI":"10.3389\/fmolb.2023.1330400","article-title":"Biogenesis and delivery of extracellular vesicles: harnessing the power of EVs for diagnostics and therapeutics","volume":"10","author":"Yu","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"B191","doi-asserted-by":"publisher","first-page":"965","DOI":"10.7150\/thno.102964","article-title":"RNA nanotherapeutics for hepatocellular carcinoma treatment","volume":"15","author":"Yuan","year":"2025","journal-title":"Theranostics"},{"key":"B192","doi-asserted-by":"publisher","first-page":"940056","DOI":"10.3389\/fonc.2022.940056","article-title":"Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma","volume":"12","author":"Zelli","year":"2022","journal-title":"Front. Oncol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1039\/c9nr10620k","article-title":"PLGA protein nanocarriers with tailor-made fluorescence\/MRI\/PET imaging modalities","volume":"12","author":"Zhang","year":"2020","journal-title":"Nanoscale"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2147\/IJN.S291421","article-title":"Immunotherapy of tumor RNA-loaded lipid nanoparticles against hepatocellular carcinoma","volume":"16","author":"Zhang","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"B195","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40364-021-00350-4","article-title":"Recent advances in systemic therapy for hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomark. Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/IJN.S388916","article-title":"Surface engineering of HEK293 cell-derived extracellular vesicles for improved pharmacokinetic profile and targeted delivery of IL-12 for the treatment of hepatocellular carcinoma","volume":"18","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1336685","DOI":"10.3389\/fphar.2023.1336685","article-title":"The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s10238-024-01463-4","article-title":"Advances in nucleic acid therapeutics: structures, delivery systems, and future perspectives in cancer treatment","volume":"24","author":"Zhang","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"B199","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12929-024-01000-1","article-title":"Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines","volume":"31","author":"Zhang","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"B200","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12951-024-02761-5","article-title":"In vivo fluorescence imaging of nanocarriers in near-infrared window II based on aggregation-caused quenching","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"B201","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40164-025-00701-z","article-title":"Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijpharm.2019.04.049","article-title":"Multifunctional drug carrier based on PEI derivatives loaded with small interfering RNA for therapy of liver cancer","volume":"564","author":"Zhao","year":"2019","journal-title":"Int. J. Pharm."},{"key":"B203","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/CJI.0000000000000496","article-title":"LOXL4 shuttled by tumor cells-derived extracellular vesicles promotes immune escape in hepatocellular carcinoma by activating the STAT1\/PD-L1 Axis","volume":"47","author":"Zhao","year":"2024","journal-title":"J. Immunother."},{"key":"B204","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13046-025-03379-7","article-title":"Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients","volume":"44","author":"Zhao","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B205","doi-asserted-by":"publisher","first-page":"17588359231225040","DOI":"10.1177\/17588359231225040","article-title":"Techniques and status of hepatic arterial infusion chemotherapy for primary hepatobiliary cancers","volume":"16","author":"Zheng","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"e12198","DOI":"10.1002\/jev2.12198","article-title":"Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles enhance siRNA delivery by tumour-homing and intracellular freeway transportation","volume":"11","author":"Zhou","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"B207","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3892\/mmr.2024.13316","article-title":"Extracellular vesicles derived from mesenchymal stem cells suppress breast cancer progression by inhibiting angiogenesis","volume":"30","author":"Zhou","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"B208","doi-asserted-by":"publisher","first-page":"TPS4187","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS4187","article-title":"GEMINI-Hepatobiliary: a phase 2 study of novel first-line immuno-oncology-based treatments in patients with advanced hepatobiliary cancers","volume":"42","author":"Zhou","year":"","journal-title":"J. Clin. Oncol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","article-title":"M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma","volume":"13","author":"Zuo","year":"2020","journal-title":"J. Hematol. Oncol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1812373\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:21:49Z","timestamp":1779949309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1812373\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":209,"alternative-id":["10.3389\/fcell.2026.1812373"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1812373","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1812373"}}